• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组分析HOXC9诱导的神经母细胞瘤细胞神经元分化

Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells.

作者信息

Wang Xiangwei, Yang Liqun, Choi Jeong-Hyeon, Kitamura Eiko, Chang Chang-Sheng, Ding Jane, Lee Eun J, Cui Hongjuan, Ding Han-Fei

出版信息

Genom Data. 2014 Dec 1;2:50-52. doi: 10.1016/j.gdata.2014.04.002.

DOI:10.1016/j.gdata.2014.04.002
PMID:25013753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4084856/
Abstract

Induction of differentiation is a therapeutic strategy in neuroblastoma, a common pediatric cancer of the sympathetic nervous system. The homeobox protein HOXC9 is a key regulator of neuroblastoma differentiation. To gain a molecular understanding of the function of HOXC9 in promoting differentiation of neuroblastoma cells, we conducted a genome-wide analysis of the HOXC9-induced differentiation program by microarray gene expression profiling and chromatin immunoprecipitation in combination with massively parallel sequencing (ChIP-seq). Here we describe in details the experimental system, methods, and quality control for the generation of the microarray and ChIP-seq data associated with our recent publication [1].

摘要

诱导分化是神经母细胞瘤(一种常见的小儿交感神经系统癌症)的一种治疗策略。同源盒蛋白HOXC9是神经母细胞瘤分化的关键调节因子。为了从分子层面理解HOXC9在促进神经母细胞瘤细胞分化中的功能,我们通过微阵列基因表达谱分析和染色质免疫沉淀结合大规模平行测序(ChIP-seq)对HOXC9诱导的分化程序进行了全基因组分析。在此,我们详细描述了与我们最近发表的论文[1]相关的微阵列和ChIP-seq数据生成的实验系统、方法和质量控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a2/4536163/8d09a7b70e3f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a2/4536163/8ca9c830b324/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a2/4536163/8d09a7b70e3f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a2/4536163/8ca9c830b324/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a2/4536163/8d09a7b70e3f/gr2.jpg

相似文献

1
Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells.全基因组分析HOXC9诱导的神经母细胞瘤细胞神经元分化
Genom Data. 2014 Dec 1;2:50-52. doi: 10.1016/j.gdata.2014.04.002.
2
HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma.HOXC9 连接细胞周期退出和神经元分化,是神经母细胞瘤的预后标志物。
Cancer Res. 2011 Jun 15;71(12):4314-24. doi: 10.1158/0008-5472.CAN-11-0051. Epub 2011 Apr 20.
3
HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation.HOXC9 通过直接调控不同的基因集合来协调神经元分化过程中的多种细胞过程。
BMC Genomics. 2013 Nov 25;14:830. doi: 10.1186/1471-2164-14-830.
4
Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation.组蛋白去甲基化酶KDM6B通过促进分化在神经母细胞瘤中具有抗肿瘤功能。
Oncogenesis. 2019 Jan 4;8(1):3. doi: 10.1038/s41389-018-0112-0.
5
Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.同源框C9通过直接抑制死亡相关蛋白激酶1的转录来抑制胶质母细胞瘤中Beclin1介导的自噬。
Neuro Oncol. 2016 Jun;18(6):819-29. doi: 10.1093/neuonc/nov281. Epub 2015 Nov 17.
6
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.Hox-C9 激活细胞凋亡的内在途径,与神经母细胞瘤的自发性消退有关。
Cell Death Dis. 2013 Apr 11;4(4):e586. doi: 10.1038/cddis.2013.84.
7
Analysis of Protein-DNA Interaction by Chromatin Immunoprecipitation and DNA Tiling Microarray (ChIP-on-chip).通过染色质免疫沉淀和DNA芯片分析蛋白质与DNA的相互作用(芯片上的染色质免疫沉淀技术)
Methods Mol Biol. 2018;1689:43-51. doi: 10.1007/978-1-4939-7380-4_4.
8
Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.人类胰腺祖细胞中 PDX1 靶基因的全基因组分析。
Mol Metab. 2018 Mar;9:57-68. doi: 10.1016/j.molmet.2018.01.011. Epub 2018 Jan 31.
9
Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.HOXC9表达在结直肠癌患者中的临床预后意义
Clin Lab. 2019 Aug 1;65(8). doi: 10.7754/Clin.Lab.2019.190122.
10
Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond.染色质免疫沉淀测序(ChIP-seq)在转录因子结合位点发现、差异基因调控机制、表观遗传标记及其他方面的作用。
Cell Cycle. 2014;13(18):2847-52. doi: 10.4161/15384101.2014.949201.

引用本文的文献

1
Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.咖啡因补充和 FOXM1 抑制增强他汀类药物在神经母细胞瘤中的抗肿瘤作用。
Cancer Res. 2023 Jul 5;83(13):2248-2261. doi: 10.1158/0008-5472.CAN-22-3450.
2
Chromosome 1p status in neuroblastoma correlates with higher expression levels of miRNAs targeting neuronal differentiation pathway.神经母细胞瘤中1号染色体短臂状态与靶向神经元分化途径的微小RNA表达水平升高相关。
In Vitro Cell Dev Biol Anim. 2023 Feb;59(2):100-108. doi: 10.1007/s11626-023-00750-w. Epub 2023 Feb 17.
3
Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy.

本文引用的文献

1
HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation.HOXC9 通过直接调控不同的基因集合来协调神经元分化过程中的多种细胞过程。
BMC Genomics. 2013 Nov 25;14:830. doi: 10.1186/1471-2164-14-830.
2
HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma.HOXC9 连接细胞周期退出和神经元分化,是神经母细胞瘤的预后标志物。
Cancer Res. 2011 Jun 15;71(12):4314-24. doi: 10.1158/0008-5472.CAN-11-0051. Epub 2011 Apr 20.
3
Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.
神经母细胞瘤中假定的预后和预测标志物的比较分析:PBX1高表达与诱导治疗反应不佳相关。
Front Oncol. 2019 Nov 15;9:1221. doi: 10.3389/fonc.2019.01221. eCollection 2019.
4
Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.皮肤 T 细胞淋巴瘤中 TOX 缺陷性肿瘤细胞的分子特征分析。
Arch Dermatol Res. 2020 Sep;312(7):513-525. doi: 10.1007/s00403-019-02000-0. Epub 2019 Nov 1.
5
Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.使用选定的蛋白质生物标志物预测神经母细胞瘤细胞对天然或合成维甲酸类药物治疗的反应。
PLoS One. 2019 Jun 12;14(6):e0218269. doi: 10.1371/journal.pone.0218269. eCollection 2019.
6
Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells.转录谱分析揭示高危人类神经母细胞瘤和小鼠神经母细胞瘤成球细胞中的共同代谢程序。
Cell Rep. 2016 Oct 4;17(2):609-623. doi: 10.1016/j.celrep.2016.09.021.
7
Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.同源框C9通过直接抑制死亡相关蛋白激酶1的转录来抑制胶质母细胞瘤中Beclin1介导的自噬。
Neuro Oncol. 2016 Jun;18(6):819-29. doi: 10.1093/neuonc/nov281. Epub 2015 Nov 17.
高危神经母细胞瘤的定义与治疗进展:来自实验室与临床的经验教训
J Clin Oncol. 2009 Mar 1;27(7):1003-4. doi: 10.1200/JCO.2008.20.2739. Epub 2009 Jan 26.
4
Chromatin immunoprecipitation and microarray-based analysis of protein location.染色质免疫沉淀及基于微阵列的蛋白质定位分析
Nat Protoc. 2006;1(2):729-48. doi: 10.1038/nprot.2006.98.
5
Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.Bmi-1以浓度依赖的方式调节I型神经母细胞瘤细胞的分化和克隆性自我更新。
J Biol Chem. 2006 Nov 10;281(45):34696-704. doi: 10.1074/jbc.M604009200. Epub 2006 Sep 18.
6
Retinoid therapy of high-risk neuroblastoma.高危神经母细胞瘤的维甲酸治疗。
Cancer Lett. 2003 Jul 18;197(1-2):185-92. doi: 10.1016/s0304-3835(03)00108-3.
7
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.p53功能丧失赋予神经母细胞瘤细胞系高水平的多药耐药性。
Cancer Res. 2001 Aug 15;61(16):6185-93.
8
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.神经母细胞瘤细胞系经细胞毒性治疗后发生p53突变的证据。
Cancer Res. 2001 Jan 1;61(1):8-13.
9
Human neuroblastoma I-type cells are malignant neural crest stem cells.人I型神经母细胞瘤细胞是恶性神经嵴干细胞。
Cell Growth Differ. 1995 Apr;6(4):449-56.
10
Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro.维甲酸诱导人神经母细胞瘤细胞在体外的生长抑制及形态分化。
J Natl Cancer Inst. 1982 Apr;68(4):589-96.